KOLLINS JOHN A enters SATSUMA PHARMACEUTICALS, INC. with 305.91K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/12/2019ACC: 0000899243-19-023446
DirectorOfficer· President and CEO
Since Sep 2019
305.91K
Baseline shares
100% direct
305.91K
Direct ownership
1 position
481.32K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, $0.0001 par value
DirectShares owned305.91K
Total
305.91K direct305.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 par value | 305.91K | Direct |
| Total | 305.91K | 305.91K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
92.81K
Shares owned
N/A
Exercise price
0.90
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
109.04K
Shares owned
N/A
Exercise price
1.04
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
13.30K
Shares owned
N/A
Exercise price
0.90
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
266.18K
Shares owned
N/A
Exercise price
4.56
Expiration
—
Exercise window
—
Total
Underlying
481.32K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 0.90 | — | — | 92.81K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.04 | — | — | 109.04K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 0.90 | — | — | 13.30K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 4.56 | — | — | 266.18K | N/A |
| Total | 481.32K | 0.00 | ||||